Enliven Therapeutics, Inc. (ELVN)
44.41
-0.76
(-1.68%)
USD |
NASDAQ |
Sep 25, 14:24
Enliven Therapeutics Cash and Short Term Investments (Quarterly) : 895.16M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 895.16M |
| March 31, 2026 | 452.40M |
| December 31, 2025 | 462.62M |
| September 30, 2025 | 477.56M |
| June 30, 2025 | 490.50M |
| March 31, 2025 | 289.56M |
| December 31, 2024 | 313.49M |
| September 30, 2024 | 291.89M |
| June 30, 2024 | 312.44M |
| March 31, 2024 | 320.56M |
| December 31, 2023 | 253.20M |
| September 30, 2023 | 263.48M |
| June 30, 2023 | 277.86M |
| March 31, 2023 | 292.10M |
| Date | Value |
|---|---|
| December 31, 2022 | 88.20M |
| September 30, 2022 | 56.30M |
| June 30, 2022 | 60.34M |
| March 31, 2022 | 72.90M |
| December 31, 2021 | 90.28M |
| September 30, 2021 | 102.84M |
| June 30, 2021 | 66.77M |
| March 31, 2021 | 75.59M |
| December 31, 2020 | 88.22M |
| September 30, 2020 | 96.09M |
| June 30, 2020 | 106.28M |
| March 31, 2020 | 105.87M |
| December 31, 2019 | 28.91M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 1.084B |
| Cocrystal Pharma, Inc. | 2.244M |
| CNBX Pharmaceuticals, Inc. | 0.0095M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 567.90M |